CALIFORNIA ST 4%

DENVER COLO CITY & CNTY BRD WTR COMMRS WTR REV 5%

HOUSTON TEX UTIL SYS REV 5%

MARYLAND ST 5%

NEW JERSEY ST 5%

NEW JERSEY ST EDL FACS AUTH REV 2%

NEW YORK N Y CITY TRANSITIONAL FIN AUTH REV 4%

NEW YORK ST URBAN DEV CORP ST SALES TAX REV 5%

TRIBOROUGH BRDG & TUNL AUTH N Y PAYROLL MOBILITY TAX 2%

The fund normally invests at least 80% of its total assets in fixed income securities that comprise the index. The index is comprised of publicly traded municipal bonds that cover the U.S. dollar denominated intermediate term tax-exempt bond market.

VanEck Intermediate Muni ETF

Click here to get full coverage on When (ITM) Moves Investors should Listen - news.stocktradersdaily.com

When (ITM) Moves Investors should Listen  news.stocktradersdaily.com

When (ITM) Moves Investors should Listen - news.stocktradersdaily.com

Click here to get full coverage on Blackhawk Bank extends ITM hours beginning today - Quad Cities Business Journal

Blackhawk Bank extends ITM hours beginning today  Quad Cities Business Journal

Blackhawk Bank extends ITM hours beginning today - Quad Cities Business Journal

Click here to get full coverage on ITM Power Secures 300MW Electrolyser Contract for Major Green Hydrogen Project in Asia-Pacific - Fuel Cells Works

ITM Power Secures 300MW Electrolyser Contract for Major Green Hydrogen Project in Asia-Pacific  Fuel Cells Works

ITM Power Secures 300MW Electrolyser Contract for Major Green Hydrogen Project in Asia-Pacific - Fuel Cells Works

Click here to get full coverage on ITM test - KNIA KRLS Radio

ITM test - KNIA KRLS Radio

Click here to get full coverage on ITM Power (OTCMKTS:ITMPF) Stock Price Up 12.5% - Here's What Happened - MarketBeat

ITM Power (OTCMKTS:ITMPF) Stock Price Up 12.5% - Here's What Happened  MarketBeat

ITM Power (OTCMKTS:ITMPF) Stock Price Up 12.5% - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Power secures 300MW electrolyser deal for APAC green hydrogen plant - Hydrogen Europe

ITM Power secures 300MW electrolyser deal for APAC green hydrogen plant  Hydrogen Europe

ITM Power secures 300MW electrolyser deal for APAC green hydrogen plant - Hydrogen Europe

Click here to get full coverage on ITM Power shares surge on major contract win - Investing.com

ITM Power shares surge on major contract win  Investing.com

ITM Power shares surge on major contract win - Investing.com

Click here to get full coverage on ITM Announces Positive Topline Results of Phase 3 COMPETE - GlobeNewswire

ITM Announces Positive Topline Results of Phase 3 COMPETE  GlobeNewswire

ITM Announces Positive Topline Results of Phase 3 COMPETE - GlobeNewswire

Click here to get full coverage on We Think ITM Power (LON:ITM) Can Afford To Drive Business Growth - Yahoo Finance

We Think ITM Power (LON:ITM) Can Afford To Drive Business Growth  Yahoo Finance

We Think ITM Power (LON:ITM) Can Afford To Drive Business Growth - Yahoo Finance

Click here to get full coverage on ITM Power Secures Major Electrolyser Supply Contract in APAC - TipRanks

ITM Power Secures Major Electrolyser Supply Contract in APAC  TipRanks

ITM Power Secures Major Electrolyser Supply Contract in APAC - TipRanks

Click here to get full coverage on ITM Power Lands 300MW Electrolyser Deal In Asia-Pacific, Reigniting Green Hydrogen Race - Hydrogen Fuel News

ITM Power Lands 300MW Electrolyser Deal In Asia-Pacific, Reigniting Green Hydrogen Race  Hydrogen Fuel News

ITM Power Lands 300MW Electrolyser Deal In Asia-Pacific, Reigniting Green Hydrogen Race - Hydrogen Fuel News

Click here to get full coverage on ITM shares details of radiopharma's phase 3 win, reveals overall survival miss - Fierce Biotech

ITM shares details of radiopharma's phase 3 win, reveals overall survival miss  Fierce Biotech

ITM shares details of radiopharma's phase 3 win, reveals overall survival miss - Fierce Biotech

Click here to get full coverage on ITM targets US approval for radiopharmaceutical after Phase III readout - Pharmaceutical Technology

ITM targets US approval for radiopharmaceutical after Phase III readout  Pharmaceutical Technology

ITM targets US approval for radiopharmaceutical after Phase III readout - Pharmaceutical Technology

Click here to get full coverage on ITM selected to supply more than 300MW of electrolysers to produce green hydrogen for use in Asian power plant - Hydrogen Insight

ITM selected to supply more than 300MW of electrolysers to produce green hydrogen for use in Asian power plant  Hydrogen Insight

ITM selected to supply more than 300MW of electrolysers to produce green hydrogen for use in Asian power plant - Hydrogen Insight

Click here to get full coverage on ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours - FirstWord Pharma

ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours  FirstWord Pharma

ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours - FirstWord Pharma

Click here to get full coverage on ITM Power seals 300-MW APAC electrolyser order - Renewables Now

ITM Power seals 300-MW APAC electrolyser order  Renewables Now

ITM Power seals 300-MW APAC electrolyser order - Renewables Now

Click here to get full coverage on ITM Power Have Signed a Contract to Supply a NEPTUNE II Unit to a Spanish Cement Producer - Fuel Cells Works

ITM Power Have Signed a Contract to Supply a NEPTUNE II Unit to a Spanish Cement Producer  Fuel Cells Works

ITM Power Have Signed a Contract to Supply a NEPTUNE II Unit to a Spanish Cement Producer - Fuel Cells Works

Click here to get full coverage on ITM Power strikes deal to supply 300MW of electrolysers to overseas power plant - Yahoo News UK

ITM Power strikes deal to supply 300MW of electrolysers to overseas power plant  Yahoo News UK

ITM Power strikes deal to supply 300MW of electrolysers to overseas power plant - Yahoo News UK

Click here to get full coverage on ITM Appoints Dr. Celine Wilke as Chief Medical Officer - GlobeNewswire

ITM Appoints Dr. Celine Wilke as Chief Medical Officer  GlobeNewswire

ITM Appoints Dr. Celine Wilke as Chief Medical Officer - GlobeNewswire

Click here to get full coverage on ITM Power Updates FY25 Guidance: Revenue Up 30%, Cash-Positive in H2 - Fuel Cells Works

ITM Power Updates FY25 Guidance: Revenue Up 30%, Cash-Positive in H2  Fuel Cells Works

ITM Power Updates FY25 Guidance: Revenue Up 30%, Cash-Positive in H2 - Fuel Cells Works

Click here to get full coverage on ITM Power Have Signed a Contract to Supply a NEPTUNE V Unit to Westnetz GmbH - Fuel Cells Works

ITM Power Have Signed a Contract to Supply a NEPTUNE V Unit to Westnetz GmbH  Fuel Cells Works

ITM Power Have Signed a Contract to Supply a NEPTUNE V Unit to Westnetz GmbH - Fuel Cells Works

Click here to get full coverage on ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 - GlobeNewswire

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225  GlobeNewswire

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 - GlobeNewswire

Click here to get full coverage on ITM Power Selected to Supply Electrolysis Modules for Uniper's 120MW Green Hydrogen Project - Fuel Cells Works

ITM Power Selected to Supply Electrolysis Modules for Uniper's 120MW Green Hydrogen Project  Fuel Cells Works

ITM Power Selected to Supply Electrolysis Modules for Uniper's 120MW Green Hydrogen Project - Fuel Cells Works

Click here to get full coverage on ITM Announces Updates to Commercial Leadership - GlobeNewswire

ITM Announces Updates to Commercial Leadership  GlobeNewswire

ITM Announces Updates to Commercial Leadership - GlobeNewswire

Click here to get full coverage on Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says - BioPharma Dive

Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says  BioPharma Dive

Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says - BioPharma Dive

Click here to get full coverage on ITM Power strikes deal to supply 300MW of electrolysers to overseas power plant - MSN

ITM Power strikes deal to supply 300MW of electrolysers to overseas power plant  MSN

ITM Power strikes deal to supply 300MW of electrolysers to overseas power plant - MSN

Click here to get full coverage on Barbara Weber, M.D., Elected to ITM Supervisory Board - GlobeNewswire

Barbara Weber, M.D., Elected to ITM Supervisory Board  GlobeNewswire

Barbara Weber, M.D., Elected to ITM Supervisory Board - GlobeNewswire

Click here to get full coverage on ITM ups FY25 revenue guidance by 30% following legacy project boost - H2 View

ITM ups FY25 revenue guidance by 30% following legacy project boost  H2 View

ITM ups FY25 revenue guidance by 30% following legacy project boost - H2 View

Click here to get full coverage on ITM Power Reaches UK£281m Market Cap Benefiting Insider Stock Buying - simplywall.st

ITM Power Reaches UK£281m Market Cap Benefiting Insider Stock Buying  simplywall.st

ITM Power Reaches UK£281m Market Cap Benefiting Insider Stock Buying - simplywall.st

Click here to get full coverage on ITM Presents Positive Topline Phase 3 COMPETE Trial Data with n.c.a. 177Lu-edotreotide (ITM-11), a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors at the ENETS 2025 Conference - GlobeNewswire

ITM Presents Positive Topline Phase 3 COMPETE Trial Data with n.c.a. 177Lu-edotreotide (ITM-11), a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors at the ENETS 2025 Conference  GlobeNewswire

ITM Presents Positive Topline Phase 3 COMPETE Trial Data with n.c.a. 177Lu-edotreotide (ITM-11), a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors at the ENETS 2025 Conference - GlobeNewswire

Click here to get full coverage on ITM-11 boosts survival in neuroendocrine tumour trial - Drug Target Review

ITM-11 boosts survival in neuroendocrine tumour trial  Drug Target Review

ITM-11 boosts survival in neuroendocrine tumour trial - Drug Target Review

Click here to get full coverage on ITM Power secures 300MW electrolyser deal for APAC green hydrogen plant - H2 View

ITM Power secures 300MW electrolyser deal for APAC green hydrogen plant  H2 View

ITM Power secures 300MW electrolyser deal for APAC green hydrogen plant - H2 View

Click here to get full coverage on Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots - statnews.com

Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots  statnews.com

Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots - statnews.com

Click here to get full coverage on ITM reports more Phase 3 radiopharma data in challenge to Novartis’ Lutathera - Endpoints News

ITM reports more Phase 3 radiopharma data in challenge to Novartis’ Lutathera  Endpoints News

ITM reports more Phase 3 radiopharma data in challenge to Novartis’ Lutathera - Endpoints News

Click here to get full coverage on ITM Power shares jump as picked for "large-scale" project - marketscreener.com

ITM Power shares jump as picked for "large-scale" project  marketscreener.com

ITM Power shares jump as picked for "large-scale" project - marketscreener.com

Click here to get full coverage on ITM’s radiotherapeutic beats out standard-of-care in Phase III trial - Clinical Trials Arena

ITM’s radiotherapeutic beats out standard-of-care in Phase III trial  Clinical Trials Arena

ITM’s radiotherapeutic beats out standard-of-care in Phase III trial - Clinical Trials Arena

Click here to get full coverage on Celine Wilke leaves Novartis to become ITM CMO - The Pharma Letter

Celine Wilke leaves Novartis to become ITM CMO  The Pharma Letter

Celine Wilke leaves Novartis to become ITM CMO - The Pharma Letter

Click here to get full coverage on Spanish cement producer taps ITM Power for 2MW electrolyser system - H2 View

Spanish cement producer taps ITM Power for 2MW electrolyser system  H2 View

Spanish cement producer taps ITM Power for 2MW electrolyser system - H2 View

Click here to get full coverage on ITM Learning reviewed in two reports - KTH Intranät

ITM Learning reviewed in two reports  KTH Intranät

ITM Learning reviewed in two reports - KTH Intranät

Click here to get full coverage on Longtime manufacturer ITM's lead radiotherapy outperforms standard of care in phase 3 neuroendocrine tumor trial - Fierce Biotech

Longtime manufacturer ITM's lead radiotherapy outperforms standard of care in phase 3 neuroendocrine tumor trial  Fierce Biotech

Longtime manufacturer ITM's lead radiotherapy outperforms standard of care in phase 3 neuroendocrine tumor trial - Fierce Biotech

Click here to get full coverage on ITM Power Selected for Major Green Hydrogen Project by Uniper - TipRanks

ITM Power Selected for Major Green Hydrogen Project by Uniper  TipRanks

ITM Power Selected for Major Green Hydrogen Project by Uniper - TipRanks

Click here to get full coverage on ITM-11 succeeds in phase 3: The first big win for radiopharma? - Labiotech.eu

ITM-11 succeeds in phase 3: The first big win for radiopharma?  Labiotech.eu

ITM-11 succeeds in phase 3: The first big win for radiopharma? - Labiotech.eu

Click here to get full coverage on Hydrogen sector: ITM, or Ceres? There's one clear winner, says investment bank - Proactive Investors

Hydrogen sector: ITM, or Ceres? There's one clear winner, says investment bank  Proactive Investors

Hydrogen sector: ITM, or Ceres? There's one clear winner, says investment bank - Proactive Investors

Click here to get full coverage on ITM Power shares jump 18% on major green hydrogen deal in Asia-Pacific - Proactive Investors

ITM Power shares jump 18% on major green hydrogen deal in Asia-Pacific  Proactive Investors

ITM Power shares jump 18% on major green hydrogen deal in Asia-Pacific - Proactive Investors

Click here to get full coverage on T-Mobile c/o ITM - Ad from 2025-05-03 - Herald-Review.com

T-Mobile c/o ITM - Ad from 2025-05-03  Herald-Review.com

T-Mobile c/o ITM - Ad from 2025-05-03 - Herald-Review.com

Click here to get full coverage on ITM Energy Progresses Despite Challenges: Boosts Revenue and Orders From Green Hydrogen Projects - Fuel Cells Works

ITM Energy Progresses Despite Challenges: Boosts Revenue and Orders From Green Hydrogen Projects  Fuel Cells Works

ITM Energy Progresses Despite Challenges: Boosts Revenue and Orders From Green Hydrogen Projects - Fuel Cells Works

Click here to get full coverage on Deutsche Bahn, ITM Power partner on clean transport and hydrogen infrastructure - H2 View

Deutsche Bahn, ITM Power partner on clean transport and hydrogen infrastructure  H2 View

Deutsche Bahn, ITM Power partner on clean transport and hydrogen infrastructure - H2 View

Click here to get full coverage on ITM Power: Shares in green hydrogen specialist skyrocket - Yahoo

ITM Power: Shares in green hydrogen specialist skyrocket  Yahoo

ITM Power: Shares in green hydrogen specialist skyrocket - Yahoo

Click here to get full coverage on ITM Power Secures NEPTUNE II Contract with Spanish Cement Producer - TipRanks

ITM Power Secures NEPTUNE II Contract with Spanish Cement Producer  TipRanks

ITM Power Secures NEPTUNE II Contract with Spanish Cement Producer - TipRanks

Click here to get full coverage on ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 - GlobeNewswire

ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225  GlobeNewswire

ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 - GlobeNewswire

Click here to get full coverage on ITM Power Enhances Executive Stakeholder Engagement with Share Incentive Plan - TipRanks

ITM Power Enhances Executive Stakeholder Engagement with Share Incentive Plan  TipRanks

ITM Power Enhances Executive Stakeholder Engagement with Share Incentive Plan - TipRanks

Click here to get full coverage on ITM appoints new chief medical officer - AuntMinnie

ITM appoints new chief medical officer  AuntMinnie

ITM appoints new chief medical officer - AuntMinnie

Click here to get full coverage on UK hydrogen electrolyser maker ITM announces 30% increase in expected 2025 revenue - Hydrogen Insight

UK hydrogen electrolyser maker ITM announces 30% increase in expected 2025 revenue  Hydrogen Insight

UK hydrogen electrolyser maker ITM announces 30% increase in expected 2025 revenue - Hydrogen Insight

Click here to get full coverage on Latham & Watkins Advises ITM on Obtaining Exclusive Worldwide License From Debiopharm for Cancer Treatment - Latham & Watkins LLP

Latham & Watkins Advises ITM on Obtaining Exclusive Worldwide License From Debiopharm for Cancer Treatment  Latham & Watkins LLP

Latham & Watkins Advises ITM on Obtaining Exclusive Worldwide License From Debiopharm for Cancer Treatment - Latham & Watkins LLP

Click here to get full coverage on ITM Power raises FY 2024/25 revenue guidance - Renewables Now

ITM Power raises FY 2024/25 revenue guidance  Renewables Now

ITM Power raises FY 2024/25 revenue guidance - Renewables Now

Click here to get full coverage on Westnetz taps ITM Power’s electrolysers for German hydrogen mobility project - H2 View

Westnetz taps ITM Power’s electrolysers for German hydrogen mobility project  H2 View

Westnetz taps ITM Power’s electrolysers for German hydrogen mobility project - H2 View

Click here to get full coverage on ITM Power’s electrolyzer solution picked for Agder hydrogen project in Norway - Offshore Energy

ITM Power’s electrolyzer solution picked for Agder hydrogen project in Norway  Offshore Energy

ITM Power’s electrolyzer solution picked for Agder hydrogen project in Norway - Offshore Energy

Click here to get full coverage on ITM Power PLC (ITMPF) (H1 2025) Earnings Call Highlights: Revenue Growth and Strategic Advancements - Yahoo Finance

ITM Power PLC (ITMPF) (H1 2025) Earnings Call Highlights: Revenue Growth and Strategic Advancements  Yahoo Finance

ITM Power PLC (ITMPF) (H1 2025) Earnings Call Highlights: Revenue Growth and Strategic Advancements - Yahoo Finance

Click here to get full coverage on ITM Power confirms 300+ MW electrolyser deal with APAC customer - Quantum Commodity Intelligence

ITM Power confirms 300+ MW electrolyser deal with APAC customer  Quantum Commodity Intelligence

ITM Power confirms 300+ MW electrolyser deal with APAC customer - Quantum Commodity Intelligence

Click here to get full coverage on ITM Power to work on 10 MW hydrogen production plant design configuration - Offshore Energy

ITM Power to work on 10 MW hydrogen production plant design configuration  Offshore Energy

ITM Power to work on 10 MW hydrogen production plant design configuration - Offshore Energy

Click here to get full coverage on ITM poll asks if TMCs are fit for the future - The Business Travel Magazine

ITM poll asks if TMCs are fit for the future  The Business Travel Magazine

ITM poll asks if TMCs are fit for the future - The Business Travel Magazine

Click here to get full coverage on ITM announces topline results of Phase 3 trial with ITM-11 - European Pharmaceutical Manufacturer

ITM announces topline results of Phase 3 trial with ITM-11  European Pharmaceutical Manufacturer

ITM announces topline results of Phase 3 trial with ITM-11 - European Pharmaceutical Manufacturer

Click here to get full coverage on ITM Power Secures NEPTUNE V Contract with Westnetz for Hydrogen Bus Fleet - TipRanks

ITM Power Secures NEPTUNE V Contract with Westnetz for Hydrogen Bus Fleet  TipRanks

ITM Power Secures NEPTUNE V Contract with Westnetz for Hydrogen Bus Fleet - TipRanks

Click here to get full coverage on New ITM radiopharmaceutical heading to the FDA for review after Phase 3 win - statnews.com

New ITM radiopharmaceutical heading to the FDA for review after Phase 3 win  statnews.com

VanEck Intermediate Muni ETF (ITM)

Price Chart

Key Statistics

Top 10 Holdings Distribution

Technicals

About ITM

Latest News

When (ITM) Moves Investors should Listen - news.stocktradersdaily.com

Blackhawk Bank extends ITM hours beginning today - Quad Cities Business Journal

ITM Power Secures 300MW Electrolyser Contract for Major Green Hydrogen Project in Asia-Pacific - Fuel Cells Works

Advanced Charts

Fund Information